Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

heart attack

6 posts
NNovartis
Lp(a) HORIZON trial: Lp(a) fell by 78%, but cardiovascular outcomes unexpectedly neutral
Read More

Lp(a) HORIZON trial: Lp(a) fell by 78%, but cardiovascular outcomes unexpectedly neutral

  • 2026-11-16
Research Highlights: In the 7-year, phase III, multicenter, international Lp(a) HORIZON trial, the novel medication pelacarsen lowered…
NNovartis
Novartis’ Lp(a) drug misses key cardiovascular goal
Read More

Novartis’ Lp(a) drug misses key cardiovascular goal

  • 2026-09-21
Trial of 8,000+ people finds cardiovascular drug fails to cut heart attacks and strokes, leaving a key longevity…
NNovartis
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
Read More

Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure

  • 2026-09-12
During the September 8 episode of Mad Money, Jim Cramer said Amgen Inc. (NASDAQ:AMGN) may have limited downside…
NNovartis
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Read More

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030

  • 2026-04-16
Novartis Pharma AG Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales…
RRoche
Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks
Read More

Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks

  • 2026-04-13
F. Hoffmann-La Roche Ltd Recently granted CE Mark, the novel test delivers improved sensitivity and accuracy for faster…
RRoche
Roche’s Gen 6 Troponin T test accurately diagnosing heart attacks
Read More

Roche’s Gen 6 Troponin T test accurately diagnosing heart attacks

  • 2026-02-18
Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is…
Switzerland
www.europesays.com